La Hulpe, Belgium

Alain Colinet

This inventor holds 2 USPTO granted patents. Top assignee: Recherche Et Industrie Therapeutiques (r.i.t.). Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alain Colinet. Retrieved from https://idiyas.com/inventor/alain-colinet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Alain Colinet

Introduction

Alain Colinet is a notable inventor based in La Hulpe, Belgium. He has made significant contributions to the field of antibacterial agents through his innovative work. With a total of two patents to his name, Colinet has established himself as a key figure in pharmaceutical research.

Latest Patents

Colinet's latest patents focus on 7-(3-Substituted ureido) cephalosporins. These compounds are characterized by a 3-substituted ureido or -thioureido group at position 7, along with hydrogen or heterocyclic thiomethyl groups at position 3. The compounds developed by Colinet serve as effective antibacterial agents, showcasing his commitment to advancing medical science.

Career Highlights

Colinet is associated with Recherche et Industrie Thérapeutiques (R.I.T.), where he has been instrumental in developing new therapeutic solutions. His work has not only contributed to the company's portfolio but has also had a broader impact on the pharmaceutical industry.

Collaborations

Colinet collaborates with Pierre Crooij, enhancing the research and development efforts at R.I.T. Their partnership exemplifies the importance of teamwork in driving innovation in the field of therapeutics.

Conclusion

Alain Colinet's contributions to antibacterial agents through his patents reflect his dedication to improving healthcare. His work continues to influence the pharmaceutical landscape, making him a significant inventor in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…